A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses

NCT00273416 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Impotence

Interventions

DRUG: PF-00592379
DRUG: Sildenafil 100mg

Sponsor

Pfizer